Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Total Voting Rights

13 Dec 2006 11:43

Creston PLC13 December 2006 13 December 2006 Creston Plc ( "Creston" or the "Company") Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6 theCompany notifies the market of the following: Creston's capital consists of 55,761,238 ordinary shares with voting rights.Creston holds 37,316 ordinary shares in Treasury. Therefore the total number ofvoting rights in Creston is 55,723,922. The above figure (55,723,922) may beused by shareholders as the denominator for the calculations by which they willdetermine if they are required to notify their interest in, or a change to theirinterest in, Creston under the FSA's Disclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.